Sponsor or institution

Clinical trials and research at Shanghai Best-Link Bioscience, LLC

• 2Clinical trials
• 1Country

All recruiting trials (2)

• Testing different doses of BL0175 injections in postmenopausal HR-positive, HER2-negative breast cancer

  This study tests different BL0175 doses to see which works best for postmenopausal patients with HR-positive, HER2-negative locally advanced or metastatic breast cancer.

  Recruiting Phase 2 Shanghai Best-Link Bioscience, LLC · Shanghai, Shanghai Municipality · NCT07658183

• BL0175 injection for postmenopausal women with HR-positive, HER2-negative advanced or metastatic breast, ovarian, or endometrial cancer

  This study will test whether BL0175 injections are safe and can help postmenopausal women whose HR-positive, HER2-negative breast, ovarian, or endometrial cancer has advanced or spread.

  Recruiting at 2 sites Phase 1 Shanghai Best-Link Bioscience, LLC · Changchun, Jilin and 1 other locations · NCT06738966

Quick answers

How many clinical trials run by Shanghai Best-Link Bioscience, LLC are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →